Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiation Retinopathy”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Early research (Phase 1)Study completedNCT01334879
What this trial is testing

High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy

Who this might be right for
Radiation Retinopathy
The New York Eye Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT00004006
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma

Who this might be right for
Retinoblastoma
St. Jude Children's Research Hospital 4
Not applicableEnded earlyNCT01415453
What this trial is testing

Evoked Retinal Response

Who this might be right for
Retinitis Pigmentosa
Columbia University 1
Not applicableUnknownNCT02483650
What this trial is testing

Hyperbaric Oxygen Therapy Registry

Who this might be right for
Air or Gas EmbolismCarbon Monoxide PoisoningClostridial Myositis and Myonecrosis (Gas Gangrene)+11 more
U.S. Wound Registry 5,000
Large-scale testing (Phase 3)Looking for participantsNCT05844982
What this trial is testing

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Who this might be right for
Radiation RetinopathyVisual Impairment
Jaeb Center for Health Research 600
Early research (Phase 1)Ended earlyNCT00623077
What this trial is testing

MT2004-30: Tomotherapy for Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more
Masonic Cancer Center, University of Minnesota 23
Very early researchStudy completedNCT00517010
What this trial is testing

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
University of California, Davis 6
Large-scale testing (Phase 3)UnknownNCT00454389
What this trial is testing

Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
NeoVista 494
Testing effectiveness (Phase 2)Study completedNCT02222610
What this trial is testing

Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.

Who this might be right for
Radiation Retinopathy
Greater Houston Retina Research 40
Large-scale testing (Phase 3)WithdrawnNCT03238157
What this trial is testing

Steroids for Early Treatment of Radiation Retinopathy

Who this might be right for
Radiation Retinopathy
The Cleveland Clinic
Not applicableActive Not RecruitingNCT03026998
What this trial is testing

MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)

Who this might be right for
Hereditary Retinoblastoma
Institut Curie 88
Post-approval studies (Phase 4)UnknownNCT00540930
What this trial is testing

Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy

Who this might be right for
Uveal MelanomaRadiation RetinopathyRadiation Maculopathy
Shields, Shields and Associates 400
Not applicableWithdrawnNCT01339949
What this trial is testing

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

Who this might be right for
Wet Age-related Macular DegenerationAge-related Macular DegenerationAMD+2 more
Oraya Therapeutics, Inc.
Not applicableUnknownNCT01516294
What this trial is testing

IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD

Who this might be right for
Polypoidal Chorodial VasculopathyAge Related Macular Degeneration
Oraya Therapeutics, Inc. 12
Not applicableUnknownNCT00360750
What this trial is testing

Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye

Who this might be right for
Retinoblastoma
Children's Cancer and Leukaemia Group
Testing effectiveness (Phase 2)Ended earlyNCT01471054
What this trial is testing

Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

Who this might be right for
Macular EdemaCystoid Macular EdemaUveal Melanoma+2 more
Arman Mashayekhi 6
Not applicableUnknownNCT02329002
What this trial is testing

SPT Screening in Irradiated Hereditary Retinoblastoma Survivors

Who this might be right for
Retinoblastoma
Amsterdam UMC, location VUmc 400
Large-scale testing (Phase 3)Study completedNCT02243878
What this trial is testing

Stereotactic Radiotherapy for Wet AMD (STAR)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
King's College Hospital NHS Trust 411
Early research (Phase 1)Study completedNCT00765921
What this trial is testing

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Who this might be right for
Choroidal Melanoma
Massachusetts Eye and Ear Infirmary 40
Testing effectiveness (Phase 2)UnknownNCT01521065
What this trial is testing

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationWet Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 500
Load More Results